
S14 Ep55: Advances in ADT Personalization and Molecular Imaging Shape Updated NCCN Prostate Cancer Recommendations: With Daniel Spratt, MD
OncLive® On Air
00:00
Cardiovascular Signals and ADT Class Differences
Spratt discusses inconclusive but potentially favorable MACE data for GnRH antagonists and need for more study.
Play episode from 08:33
Transcript


